Open original FDA record ↗Recall record
- FDA identifier
- Z-0638-2024
- Company in FDA record
- Philips Respironics, Inc.
- FDA classification date
- Jan 4, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The following was missing from the Contraindications Statement: The AVAPS-AE therapy mode is contraindicated for invasive use and patients less than 10 kg. The AVAPS feature is contraindicated for patients less than 10 kg. Potential harms if devices are used on contraindicated patients include barotrauma, hypoventilation/hypercapnia, and rebreathing of excessive CO2.
Source facts
- Action
- On November 27, 2023, the firm sent "URGENT Medical Device Correction" letters to dated November 20, 2023, affected customers along with an attached manual addendum for insertion into current manuals. Customers were instructed to keep a copy of the letter and attached addendum with their Trilogy Evo or Trilogy Evo O2 Ventilator IFUs. Distributors were instructed to notify any customers to whom they have distributed affected devices. If you need any further information or support concerning this issue, please contact your local Philips representative: Call 1-(877)-387-3311 or email at patientsupport@philips.com
- Initiated
- 2023-11-27
- Root cause
- Device Design
- Distribution
- Worldwide distribution: US (nationwide)-AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY, Including PR; and OUS (International) including countries of: AE, AR,AT, AU, BD, BE, BG, BO, BR, CA, CH, CL, CN, CO, CZ, DE, DK, DZ, ;EC EE, EG, ES, FI, FR, GB, GE, GF, GR, GT, HK, HR, HU, IE, IL, IN, IT, JO, JP, KE, KR, KW, LB, LT, MA, ME, MK, MM, MQ, MT, MX, MY, NG, NL, NO, NP, OM, PA, PE, PF, PH, PK, PL, PR, PT, PY, QA, RE, RO, RS, RU, SA, SE, SG, SI, SK, TH, TN, TR, TW, UA, YT, ZA and ZW.
- Recall number
- Z-0638-2024
- Recall status
- Open, Classified
- CDRH record ID
- 204961
- FDA classified
- 2024-01-04
- Recall event number
- 93609